Strategic Investment Advisors / MI

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 1760540 FARMINGTON HILLS, MI

Position in VRTX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$370,560

+$9,310 QoQ

Shares Held

746

-7.8% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.07%

of 13F equity value

Holder Rank

#1,162

of 1,732 holders

Holding Since

Sep 2022

16 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Strategic Investment Advisors / MI holds $2,978,396 across 4 Biotechnology names. VRTX ranks #2 (12.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	EXEL	Exelixis, Inc.	43,048	$2,342,241
2	VRTX	Vertex Pharmaceuticals Inc / Ma This page	746	$370,560
3	GMAB	Genmab A/S	5,653	$155,287
4	DFTX	Definium Therapeutics, Inc.	2,345	$110,308

16 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$370,560	746	-7.8%	Shares	Sole	2026-08-14
2026-03-31	$361,250	809	-46.5%	Shares	Sole	2026-05-18
2025-12-31	$685,026	1,511	-8.4%	Shares	Sole	2026-02-17
2025-09-30	$646,206	1,650	-7.0%	Shares	Sole	2025-12-17
2025-06-30	$789,784	1,774	+2.2%	Shares	Sole	2025-08-15
2025-03-31	$841,162	1,735	-2.9%	Shares	Sole	2025-04-23
2024-12-31	$719,222	1,786	-0.1%	Shares	Sole	2025-01-22
2024-09-30	$831,097	1,787	-69.1%	Shares	Sole	2024-10-21
2024-06-30	$2,714,826	5,792	-3.1%	Shares	Sole	2024-07-23
2024-03-31	$2,499,281	5,979	+1.1%	Shares	Sole	2024-04-23
2023-12-31	$2,405,533	5,912	-31.8%	Shares	Sole	2024-01-10
2023-09-30	$3,012,819	8,664	-48.0%	Shares	Sole	2023-10-25
2023-06-30	$5,860,708	16,654	+88.8%	Shares	Sole	2023-08-14
2023-03-31	$2,779,547	8,822	+49.3%	Shares	Sole	2023-04-27
2022-12-31	$1,706,689	5,910	+18.5%	Shares	Sole	2023-01-20
2022-09-30	$1,443,646	4,986	—	Shares	Sole	2022-10-27
No filing history on record for this holder in this stock.